Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study
DOI10.1080/01621459.2018.1527226zbMATH Open1428.62339OpenAlexW2587164760MaRDI QIDQ5208089FDOQ5208089
Authors: Fei Jiang, Lu Tian, Haoda Fu, Takahiro Hasegawa, L. J. Wei 
Publication date: 15 January 2020
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: https://biostats.bepress.com/harvardbiostat/paper209
Recommendations
- Robustness of ANCOVA in randomized trials with unequal randomization
- ANCOVA: an approach based on a robust heteroscedastic measure of effect size
- A randomization-based perspective on analysis of variance: a test statistic robust to treatment effect heterogeneity
- ANCOVA based on comparing a robust measure of location at empirically determined design points
- Robust ANCOVA: Some Small-sample Results when there are Multiple Groups and Multiple Covariates
- An alternative robust estimator of average treatment effect in causal inference
- Robust design in a two treatment comparison in the presence of a covariate
- Paired Comparisons for Multiple Characteristics: An ANOCOVA Approach
Applications of statistics to biology and medical sciences; meta analysis (62P10) Analysis of variance and covariance (ANOVA) (62J10)
Cites Work
- Model-Free Feature Screening for Ultrahigh-Dimensional Data
- Improving the efficiency of the log-rank test using auxiliary covariates
- Title not available (Why is that?)
- Doubly Robust Estimation in Missing Data and Causal Inference Models
- Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
- Matching methods for causal inference: a review and a look forward
- Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
- The Robust Inference for the Cox Proportional Hazards Model
- Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates
- Misspecified proportional hazard models
- Ancillaries and conditional inference (with comments and rejoinder)
- Title not available (Why is that?)
- Some Problems Connected with Statistical Inference
- Title not available (Why is that?)
- Title not available (Why is that?)
- Title not available (Why is that?)
- Some remarks on conditional and unconditional inference for location-scale models
- Title not available (Why is that?)
- Semiparametric Estimation of Treatment Effect in a Pretest‐Posttest Study
- On the restricted mean survival time curve in survival analysis
- On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial
Cited In (7)
- Bayesian adaptive design for covariate-adaptive historical control information borrowing
- Covariate-adjusted Fisher randomization tests for the average treatment effect
- Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment
- Sample size calculation for the augmented logrank test in randomized clinical trials
- Target estimands for population-adjusted indirect comparisons
- Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes
- ANCOVA: an approach based on a robust heteroscedastic measure of effect size
This page was built for publication: Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5208089)
